^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    HB0045

    i
    Other names: HB0045
    Associations

    News

    Trials
    Company:
    Zhejiang Huahai Pharma
    Drug class:
    CD73 inhibitor
    Related drugs:
    Associations

    News

    Trials
    1year
    A Study of HB0045 Injection in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=71, Recruiting, Shanghai Huaota Biopharmaceutical Co., Ltd. | Not yet recruiting --> Recruiting
    Enrollment open • Metastases
    |
    MSI (Microsatellite instability) • CD4 (CD4 Molecule)
    |
    HB0045
    1year
    A Study of HB0045 Injection in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=71, Not yet recruiting, Shanghai Huaota Biopharmaceutical Co., Ltd.
    New P1/2 trial • Metastases
    |
    MSI (Microsatellite instability) • CD4 (CD4 Molecule)
    |
    HB0045
    over1year
    A Study of HB0045 Injection in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1/2, N=71, Not yet recruiting, Huabo Biopharm Co., Ltd.
    New P1/2 trial • Metastases
    |
    MSI (Microsatellite instability) • CD4 (CD4 Molecule)
    |
    HB0045